TipRanks
Go Ultimate55% OFF

Humana (HUM) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

HUM Analyst Ratings

Moderate Buy
17Ratings
12Buy5Hold0Sell
Based on 17 analysts giving stock ratings to Humana in the past 3 months

HUM Stock 12 Month Forecast

EUR 423.74▲(14.52% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is EUR 423.74 with a high forecast of EUR 533.51 and a low forecast of EUR 331.21. The average price target represents a 14.52% change from the last price of EUR 370.00.
Highest Price TargetEUR 533.51Average Price TargetEUR 423.74Lowest Price TargetEUR 331.21

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:HUM
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
GuggenheimEUR 421.62buy13.95%UpsideReiterated10/20/26
BarclaysEUR 520.98buy40.80%UpsideReiterated10/14/26
Mizuho SecuritiesEUR 418.93→EUR 443.10buy19.76%UpsideReiterated10/13/26
Evercore ISIEUR 429.67buy16.13%UpsideReiterated10/13/26
Raymond JamesEUR 465.48buy25.80%UpsideUpgraded10/12/26
Truist FinancialEUR 371.49→EUR 425.20hold14.92%UpsideReiterated10/12/26
UBSEUR 362.54→EUR 443.10hold19.76%UpsideAssigned10/12/26
Robert W. BairdEUR 349.11→EUR 533.51buy44.19%UpsideUpgraded10/09/26
OppenheimerEUR 362.54→EUR 425.20buy14.92%UpsideReiterated10/09/26
Cantor FitzgeraldEUR 411.77buy11.29%UpsideUpgraded10/07/26
RBC CapitalEUR 371.49hold0.40%UpsideReiterated10/07/26
BernsteinEUR 380.44buy2.82%UpsideReiterated10/05/26
JefferiesEUR 558.57→EUR 375.96buy1.61%UpsideReiterated09/30/26
Wells FargoEUR 449.37buy21.45%UpsideReiterated09/15/26
Bank of America Securities―buy―Assigned09/08/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

3 Months
Lance Wilkes
Lance WilkesBernstein
Success Rate13/17 ratings generated profit
76%
Average Return
+19.58%

Copying Lance Wilkes's trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +19.58% per trade.

1 Year
Lance Wilkes
Lance WilkesBernstein
Success Rate13/17 ratings generated profit
76%
Average Return
+34.81%

Copying Lance Wilkes's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +34.81% per trade.

2 Years
Lance Wilkes
Lance WilkesBernstein
Success Rate17/17 ratings generated profit
100%
Average Return
+58.24%

Copying Lance Wilkes's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +58.24% per trade.

HUM Analyst Recommendation Trends

020406080Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for HUM
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy01110
Buy1317161919
Hold242320177
Sell34320
Strong Sell00000
total4045403926

In the current month, HUM has received 19 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. HUM average Analyst price target in the past 3 months is 423.74.

HUM Financial Forecast

EUR -5EUR -1.25EUR 2.5EUR 6.25EUR 10Q4 2025Q2 2026Q3 2026
HighEUR -0.54
ConsensusEUR -0.89
LowEUR -1.04

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is -EUR 0.89 with a range of -EUR 1.04 to -EUR 0.54. The previous quarter’s EPS was EUR 6.79. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

EUR 29BEUR 31BEUR 33BEUR 35BEUR 37BQ4 2025Q2 2026Q3 2026
HighEUR 37B
ConsensusEUR 36.5B
LowEUR 36.1B

HUM Sales Forecast

Next quarter’s sales forecast for HUM is EUR 36.48B with a range of EUR 36.08B to EUR 36.98B. The previous quarter’s sales results were EUR 36.47B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Stock Forecast FAQ

What is DE:HUM’s average 12-month price target, according to analysts?
Based on analyst ratings, Humana’s 12-month average price target is €423.74.
What is DE:HUM’s upside potential, based on the analysts’ average price target?
Humana has 14.52% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Humana a Buy, Sell or Hold?
Humana has a consensus rating of Moderate Buy, which is based on 12 buy ratings, 5 hold ratings and 0 sell ratings.
What is Humana’s share price target?
The average share price target for Humana is €423.74. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €533.51, and the lowest forecast is €331.21. The average share price target represents a 14.52% increase from the current price of €370.
What do analysts say about Humana?
Humana’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Humana?
To buy shares of DE:HUM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.